EPO and anemia: 2OG dioxygenases, such as the PHDs and FIH, are amenable to inhibition by small molecules, and PHIs are currently in advanced stages of clinical studies for the treatment of anemia through the HIF-mediated up-regulation of EPO (2, 21, –, 23).